Franklin Resources’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66M Buy
714,804
+64,089
+10% +$6.03M 0.02% 560
2025
Q4
$51.4M Buy
650,715
+49,578
+8% +$3.56M 0.01% 627
2025
Q3
$44.1M Buy
601,137
+7,541
+1% +$479K 0.01% 685
2025
Q2
$30.2M Buy
593,596
+241
+0% +$10.7K 0.01% 796
2025
Q1
$26.7M Buy
593,355
+2,693
+0.5% +$127K 0.01% 815
2024
Q4
$24.4M Sell
590,662
-1,994
-0.3% -$83.1K 0.01% 836
2024
Q3
$23.6M Sell
592,656
-348,914
-37% -$13.9M 0.01% 847
2024
Q2
$32.2M Buy
941,570
+196
+0% +$5.14K 0.01% 701
2024
Q1
$23.6M Buy
941,374
+28,306
+3% +$778K 0.01% 814
2023
Q4
$27M Buy
913,068
+168,446
+23% +$5.1M 0.01% 681
2023
Q3
$23.5M Buy
744,622
+133,541
+22% +$3.66M 0.01% 700
2023
Q2
$15.8M Buy
611,081
+210,579
+53% +$5.6M 0.01% 829
2023
Q1
$9.62M Buy
400,502
+20
+0% +$456 ﹤0.01% 938
2022
Q4
$7.81M Sell
400,482
-1,135,642
-74% -$22.4M ﹤0.01% 1007
2022
Q3
$32.3M Buy
1,536,124
+287,002
+23% +$6.91M 0.02% 646
2022
Q2
$24.3M Buy
1,249,122
+578
+0% +$13.6K 0.01% 745
2022
Q1
$27.5M Buy
1,248,544
+764,441
+158% +$15.6M 0.01% 768
2021
Q4
$7.72M Buy
+484,103
New +$7.53M ﹤0.01% 1120

Other funds holding MIRM

Franklin Resources's MIRM Position: Q1 2026 in Review

Franklin Resources increased its Mirum Pharmaceuticals (MIRM) stake by 9.8% in Q1 2026, buying an estimated $6.03M and bringing the position to 714,804 shares worth $66M. The position accounts for 0.02% of the portfolio, ranked #560.

Franklin Resources first reported a position in MIRM in Q4 2021 and has held it in 18 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Franklin Resources held 714,804 shares of Mirum Pharmaceuticals worth $66M as of Q1 2026.
  • Franklin Resources bought 64,089 Mirum Pharmaceuticals shares in Q1 2026, an estimated $6.03M.
  • Mirum Pharmaceuticals made up 0.02% of Franklin Resources's portfolio in Q1 2026, its #560 holding.
  • Franklin Resources first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.